Advancing Research
by funding Grant Programs and Fellowships.
Driving Innovation
by guiding the the advancing the study of healthy aging through the Blue Zones Research Institute, the FAST Initiative, and the SuperAgers Initiative.
Furthering the Field
by supporting the infrastructure of three NIA Initiatives and leading the Amplifying Geroscience Initiative.
Top Breakthroughs driven by AFAR Experts
Delaying Disease by Targeting Aging
Saving Costs by Extending Healthspan
What are the Hallmarks of Aging?
What is Geroscience?
What is the Longevity Dividend?
Dr. Gibson’s research focuses on myelin-forming oligodendroglia, the cells that wrap around and insulate the axons connecting neurons, allowing for efficient neural communication within the brain. Specifically, her lab aims to understand how these cells contribute to the regulation of sleep and cognition in aging. Her lab identified alterations in neuropeptide S signaling, a known regulator of sleep and cognition, in oligodendrocytes with aging. Her AFAR-supported research focuses on deciphering the role of neuropeptide S signaling between neurons and oligodendroglia in the regulation of sleep, and how this may change with aging and contribute to aging-associated cognitive decline.
